Covalon Technologies Ltd
XTSX:COV

Watchlist Manager
Covalon Technologies Ltd Logo
Covalon Technologies Ltd
XTSX:COV
Watchlist
Price: 3.55 CAD -2.2% Market Closed
Market Cap: 97.3m CAD
Have any thoughts about
Covalon Technologies Ltd?
Write Note

Covalon Technologies Ltd
Income from Continuing Operations

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Covalon Technologies Ltd
Income from Continuing Operations Peer Comparison

Comparables:
B
DRUG
TH
RPTX
AUPH
EDT

Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
Covalon Technologies Ltd
XTSX:COV
Income from Continuing Operations
-CA$823.4k
CAGR 3-Years
52%
CAGR 5-Years
33%
CAGR 10-Years
N/A
B
Bright Minds Biosciences Inc
CNSX:DRUG
Income from Continuing Operations
-CA$7.4m
CAGR 3-Years
-149%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Theratechnologies Inc
TSX:TH
Income from Continuing Operations
-$3.2m
CAGR 3-Years
51%
CAGR 5-Years
15%
CAGR 10-Years
10%
Repare Therapeutics Inc
NASDAQ:RPTX
Income from Continuing Operations
-$93.8m
CAGR 3-Years
-21%
CAGR 5-Years
-46%
CAGR 10-Years
N/A
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Income from Continuing Operations
-$50.4m
CAGR 3-Years
30%
CAGR 5-Years
4%
CAGR 10-Years
-12%
Spectral Medical Inc
TSX:EDT
Income from Continuing Operations
-CA$18.3m
CAGR 3-Years
-32%
CAGR 5-Years
-51%
CAGR 10-Years
-5%

See Also

What is Covalon Technologies Ltd's Income from Continuing Operations?
Income from Continuing Operations
-823.4k CAD

Based on the financial report for Jun 30, 2024, Covalon Technologies Ltd's Income from Continuing Operations amounts to -823.4k CAD.

What is Covalon Technologies Ltd's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 5Y
33%

Over the last year, the Income from Continuing Operations growth was 85%. The average annual Income from Continuing Operations growth rates for Covalon Technologies Ltd have been 52% over the past three years , 33% over the past five years .

Back to Top